Management of anovulation associated with polycystic ovarian syndrome: a randomised trial of clomid versus clomid plus metformin.

ISRCTN ISRCTN77388772
DOI https://doi.org/10.1186/ISRCTN77388772
Protocol serial number N0112128478
Sponsor Department of Health
Funder Epsom and St Helier University Hospitals NHS Trust (UK)
Submission date
30/09/2004
Registration date
30/09/2004
Last edited
19/02/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Ramasamy Chandra
Scientific

Epsom and St. Helier NHS Trust
Women's Health
St Helier Hospital
Wrythe Lane
Carshalton
SM5 1AA
United Kingdom

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Scientific title
Study objectivesClomid plus metamorformin is a better treatment option than Clomid alone for subfertility associated with polycystic ovarian syndrome.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedNutritional, Metabolic, Endocrine: PolyCystic Ovarian Syndrome (PCOS)
InterventionWomen will be randomised in blocks of six into two groups. One group will receive Clomid plus Metformin and the second group will receive Clomid alone.
Intervention typeDrug
PhaseNot Specified
Drug / device / biological / vaccine name(s)clomid versus clomid plus metformin
Primary outcome measure(s)

Pregnancy.

Key secondary outcome measure(s)

1. Ovulation
2. Level of luteinising hormone
3. Level of testosterone
4. Body Mass Index.

Completion date31/12/2007

Eligibility

Participant type(s)Patient
Age groupAdult
SexFemale
Key inclusion criteriaSubfertile women attending St Helier hospital fertility clinic with problem of anovulation associated with polycystic ovarian syndrome.
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/11/2003
Date of final enrolment31/12/2007

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Epsom and St. Helier NHS Trust
Carshalton
SM5 1AA
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan